Unknown

Dataset Information

Growth Differentiation Factor 15: A Novel Growth Biomarker for Children With Congenital Heart Disease.


ABSTRACT:

Background

Failure to thrive (FTT), defined as weight or height less than the lowest 2.5 percentile for age, is prevalent in up to 66% of children with congenital heart disease (CHD). Risk stratification methods to identify those who would benefit from early intervention are currently lacking. We aimed to identify a novel growth biomarker to aid clinical decision-making in children with CHD.

Methods

This is a cross-sectional study of patients 2 months to 10 years of age with any CHD undergoing cardiac surgery. Preoperative weight-for-age Z scores (WAZ) and height-for-age Z scores (HAZ) were calculated and assessed for association with preoperative plasma biomarkers: growth differentiation factor 15 (GDF-15), fibroblast growth factor 21, leptin, prealbumin, and C-reactive pro

SUBMITTER: Paneitz DC 

PROVIDER: S-EPMC10947752 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature